In 2019, approximately 40% of oncology patients in the United States were eligible for treatment with immune checkpoint inhibitors (ICIs). Furthermore, it is estimated that one in seven patients who ...

An interview with Dr. Bryan Schneider from the University of Michigan Health System and Dr. Kathryn Bollin from Scripps MD Anderson Cancer Center, co-chairs of the Management of Immune-Related Adverse ...

The preeminent guidelines for the diagnosis and management of hypoparathyroidism (hypoPT) are the 2022 Evaluation and Management Guidelines, developed by the Second International Workshop on hypoPT.

The International Association for Healthcare Safety and Security (IAHSS) released its latest guideline on threat management March 7. The guideline establishes a framework for healthcare organizations ...